Crossmark

Integrated network pharmacology and bioinformatics to identify therapeutic targets and molecular mechanisms of Huangkui Lianchang Decoction for ulcerative colitis treatment

Crossref DOI link: https://doi.org/10.1186/s12906-024-04590-3

Published Online: 2024-07-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

He, Zongqi

Xu, Xiang

Chen, Yugen

Huang, Yuyu

Wu, Bensheng

Xu, Zhizhong

Du, Jun

Zhou, Qing

Cheng, Xudong
License Information

Text and Data Mining valid from 2024-07-23

Version of Record valid from 2024-07-23
More Information

Article History

Received: 30 May 2023

Accepted: 16 July 2024

First Online: 23 July 2024

Declarations

:

: The animal experimental procedures conformed to animal ethics requirements and were approved by the Experimental Animal Ethics Committee of Suzhou TCM Hospital, under Grant No. 2020 Ethical Animal Approval 002. The study was conducted by the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2020/63/EU in Europe to protect the experimental animals. The study followed the ARRIVE guidelines 2.0 for design, analysis, and reporting. The anesthesia and euthanasia methods we used during the experiment were referenced from the American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals (2020).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below